Suppr超能文献

[乳腺外科领域的再生治疗选择]

[Options for regenerative therapy in the field of breast surgery].

作者信息

Prantl L, Heine N

机构信息

Center of Plastic and Aesthetic, Hand and Reconstructive Surgery, University of Regensburg.

出版信息

Handchir Mikrochir Plast Chir. 2012 Apr;44(2):103-11. doi: 10.1055/s-0031-1297966. Epub 2012 Apr 11.

Abstract

Besides the established techniques of pediculed and free tissue transplantations for breast reconstruction, adipose tissue engineering and structural fat grafting are being applied as options for regenerative therapy. While the initial euphoria about the foreseeable realisation of cell-matrix entities of sufficient size, functionality and long-term volume stability for use in humans has diminished somewhat, fat grafting as experienced a renaissance in recent years. One of the decisive factors for the engraftment of the tissue graft generated though tissue engineering is the formation of an adequate vascular network. Improvements of the matrix, which ideally should mimic natural tissue, such as the use of adipose-derived stem cells (ASCs) that can contribute both to adipogenesis and neoangiogenesis represent promising new approaches. In autologous fat grafting, the mixing of adipocytes and cells of the stromal-vascular fraction (SVF) in order to generate the principle of an inductive microenvironment has already been applied successfully in clinical routine. On the basis of the experimental data that demonstrate an interaction of the adipocytes, ASCs and other progenitor cells with breast cancer cells and the insufficient clinical data regarding oncological safety, this procedure should only be used critically. A concluding evaluation will only be possible after long-term clinical studies have provided good results.

摘要

除了用于乳房重建的带蒂和游离组织移植的既定技术外,脂肪组织工程和结构性脂肪移植正被用作再生治疗的选择。虽然最初对可预见地实现足够大小、功能和长期体积稳定性的细胞 - 基质实体以供人类使用的兴奋之情有所减弱,但脂肪移植近年来经历了复兴。通过组织工程产生的组织移植物植入的决定性因素之一是形成足够的血管网络。基质的改进,理想情况下应模仿天然组织,例如使用既能促进脂肪生成又能促进新血管生成的脂肪来源干细胞(ASC),代表了有前景的新方法。在自体脂肪移植中,为了产生诱导性微环境的原理而将脂肪细胞与基质血管成分(SVF)的细胞混合,已经在临床常规中成功应用。基于证明脂肪细胞、ASC和其他祖细胞与乳腺癌细胞相互作用的实验数据以及关于肿瘤学安全性的临床数据不足,该程序应谨慎使用。只有在长期临床研究取得良好结果后才能进行最终评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验